REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/23/2026
Back to search
Official data from USPTO
XIIDRA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
03/24/2026
Trademark type
Combined
Nice classes
5
Filing date
06/29/2020
Registration date
03/23/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/23/2021
Last transaction
03/24/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
77
Owner location
IE
Examiner
MAYES, LAURIE ANN
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "xiidra" in lower-case letters beneath a design suggestive of a stylized eye lens formed by a shaded crescent shape in between two upwardly curved lines.
Holders and representatives
Holders
Bausch + Lomb Ireland Limited
NOVARTIS AG
Representatives
Nancy L. Rowe Bausch + Lomb
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publications
History of USPTO decisions and trademark events.
39 publications found
CHLD
CHANGE OF OWNER RECEIVED FROM IB
05/10/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/17/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
03/17/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/17/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/17/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/17/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/17/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/24/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/02/2021
FIMP
FINAL DISPOSITION PROCESSED
07/02/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/23/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
03/23/2021
GPNX
NOTIFICATION PROCESSED BY IB
01/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/05/2021
PUBO
PUBLISHED FOR OPPOSITION
01/05/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/23/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/23/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/16/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/19/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/19/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/19/2020
RFNT
REFUSAL PROCESSED BY IB
11/09/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/19/2020
RFRR
REFUSAL PROCESSED BY MPU
10/19/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/02/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/02/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/02/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/02/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/02/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/02/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/25/2020
CNRT
NON-FINAL ACTION WRITTEN
09/24/2020
MAFR
APPLICATION FILING RECEIPT MAILED
09/19/2020
DOCK
ASSIGNED TO EXAMINER
09/18/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/15/2020
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
09/14/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/10/2020
Continuous trademark protection
Get notified about every new filing that threatens XIIDRA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.